Associate Director, Study Operation Manager - Nonclinical Toxicology

Centessa Pharmaceuticals • Boston, MA, US • published 2026-09-23 11:43:00.910564

Description

*Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company,* *is a clinical\-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep\-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750\) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical\-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions.* *Headquartered in Boston, Massachusetts, Centessa was recognized as a* ***Great Place to Work****® in 2026\.* **Description of Role** Centessa Pharmaceuticals is seeking an experienced **Associate Director, Study Operations \- Nonclinical Toxicology** to manage and oversee day\-to\-day operations for toxicology and safety pharmacology studies conducted in the selected CROs to include study forecasting, budgeting, planning, data management, quality assurance, compliance, communications and collaboration with different functional teams across the portfolio of...

Get jobs like this daily in Telegram: @careeri_bot